Cargando…
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
Many cancer therapies produce toxic side effects whose molecular mechanisms await full elucidation. The most feared and studied side effect of chemotherapeutic drugs is cardiotoxicity. Also, skeletal muscle physiology impairment has been recorded after many chemotherapeutical treatments. However, on...
Autores principales: | Gorini, Stefania, De Angelis, Antonella, Berrino, Liberato, Malara, Natalia, Rosano, Giuseppe, Ferraro, Elisabetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878876/ https://www.ncbi.nlm.nih.gov/pubmed/29743983 http://dx.doi.org/10.1155/2018/7582730 |
Ejemplares similares
-
Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019) -
Doxorubicin cardiotoxicity and target cells: a broader perspective
por: De Angelis, Antonella, et al.
Publicado: (2016) -
Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity
por: Piegari, Elena, et al.
Publicado: (2020) -
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat
por: Piegari, Elena, et al.
Publicado: (2016) -
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
por: Cappetta, Donato, et al.
Publicado: (2017)